EP MedSystems v. EchoCath
This article was originally published in The Gray Sheet
Executive Summary
Settlement of 1998 litigation relating to an investment by EP in EchoCath includes a payment of $30,000 to cardiac electrophysiology manufacturer EP. The latter firm also agreed to convert its EchoCath preferred stock into 300,000 shares of EchoCath common stock and additional warrants. EP received a non-exclusive license to seven of EchoCath's patents regarding ultrasound imaging technology...